[144] GENPACT LIMITED SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Genpact Limited (symbol: G) discloses a proposed sale of 25,539 common shares through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $1,164,468.47 and approximately 174,270,076 shares outstanding. The shares were acquired as performance shares: 17,608 on 01/10/2022 and 7,931 on 01/10/2023. No securities were reported sold by the selling person in the past three months. The filer certifies they are unaware of any undisclosed material adverse information and follows the Rule 144 disclosure process.

Positive

• Clear disclosure of planned sale details including broker, sale date, share count, and aggregate market value
• Securities were awarded as performance shares with acquisition dates provided, supporting transparency
• No reported sales in the prior three months, indicating this is not part of an ongoing rapid disposition

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 filing disclosing an insider's planned sale of performance shares worth ~$1.16M; appears compliant and non-material.

The filing documents a standard Rule 144 notice: a sale of 25,539 common shares via Morgan Stanley Smith Barney on NYSE with an aggregate value of $1,164,468.47. The shares were awarded as performance shares in 2022 and 2023, which the filer discloses clearly. There are no sales in the prior three months, and the signature statement affirms no undisclosed material adverse information. From a compliance standpoint, the form supplies required acquisition dates, share counts, broker details, and planned sale date, supporting orderly, rule-based disposition of restricted or controlled shares.

Equity Markets Analyst

TL;DR: The disclosed sale size (~$1.16M) is small relative to a large-cap issuer and unlikely to be market-moving.

The notice shows an insider intends to sell 25,539 common shares valued at about $1.16 million against ~174.27 million shares outstanding. Given those totals, the transaction represents a small fraction of outstanding equity and lacks other red flags such as recent accelerated sales. The classification of the shares as performance shares and the absence of recent sales suggest routine vesting and monetization rather than a liquidity-driven exit. Impact on the stock from this single filing is likely neutral.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25539	1164468.47	174270076	08/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/10/2022	Performance Shares	Issuer			17608	01/10/2022	Not Applicable
Common	01/10/2023	Performance Shares	Issuer			7931	01/10/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Genpact (G) Form 144 disclose?

The notice discloses a proposed sale of 25,539 common shares valued at $1,164,468.47 to be executed on 08/22/2025 via Morgan Stanley Smith Barney LLC on the NYSE.

How were the shares to be sold by the filer acquired?

The shares were acquired as performance shares: 17,608 on 01/10/2022 and 7,931 on 01/10/2023.

Has the filer sold other Genpact shares in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Which broker and exchange are involved in the proposed sale?

The broker is Morgan Stanley Smith Barney LLC, and the sale is to occur on the NYSE.

What does the filer certify regarding material information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.